Stem cell transplantation

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

SCT; SZT

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Transfer of blood stem cells from a donor to a recipient. In autologous SZT, donor and recipient are one and the same person; in allogeneic transplantation, they are two different people.

General definitionThis section has been translated automatically.

  • A distinction is made between:
    • autologous stem cell transplantation
    • allogenic stem cell transplantation.
  • Autologous stem cell transplantation: In this procedure, the stem cells are taken from the patient himself and reinfused at a later time. The actual transplantation of the stem cells is preceded by a high-dose, usually myeloablative chemotherapy and/or radiotherapy, the so-called conditioning phase. The subsequent stem cell transplantation replaces the bone marrow destroyed by the myeloablative conditioning therapy and shortens the therapy-related aplasia phase.
  • Allogeneic stem cell transplantation: In this procedure, the patient is given the stem cells of another, healthy stem cell donor. As with autologous stem cell transplantation, a myeloablative conditioning treatment is also performed. This has 2 objectives: the eradication of malignant cells and the immunosuppression of the recipient to avoid rejection of the transplant.

Complication(s)This section has been translated automatically.

Acute and chronic graft-versus-host disease(GvHD) is one of the most serious complications of allogeneic stem cell transplantation and can be fatal in advanced stages. Acute Graft-versus-Host D isease is the consequence of the activation of donor T cells by recipient antigens and affects the skin, intestine and liver. It occurs within the first 100 days. Symptoms occurring later are called chronic GvHD.

Authors

Last updated on: 29.10.2020